IBRX News
ImmunityBio, Inc.
$9.91
+$0.11(+1.12%)
55
Overall
40
Value
75
Tech
50
Quality
Market Cap
$10.50B
Volume
30.23M
52W Range
$1.95 - $12.43
Target Price
$12.60
IBRX news: the latest ImmunityBio, Inc. headlines, press releases and market updates, newest first.
Latest IBRX News
- Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), ImmunityBio (IBRX) and vTv Therapeutics (VTVT)TipRanks Newsroom · Oct 15, 2026
- ImmunityBio gains FDA expansion for ANKTIVA bladder therapyTipRanks Auto-Generated Newsdesk · Oct 14, 2026
- ImmunityBio’s New Sepsis Trial: Early-Stage Data With High-Stakes Market PotentialTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 25, 2026
- ImmunityBio’s New Bladder Cancer Combo Trial: What Investors Should KnowTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 24, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IBRX | $9.91 | +1.1% | 30.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |